Advertisement
Abstract| Volume 46, SUPPLEMENT 2, e44, January 2018

Novel paradigm for the development of preclinical diagnosis of Parkinson’s disease based on searching blood markers and a provocation test

DOI:https://doi.org/10.1016/j.parkreldis.2017.11.146
Novel paradigm for the development of preclinical diagnosis of Parkinson’s disease based on searching blood markers and a provocation test
Previous ArticleMolecular mechanisms of neurodegeneration and neuroplasticity in the nigrostriatal system at modeling Parkinson’s disease as an instrument for translational medicine
Next ArticleShort-term memory defects and emotional changes following sleep deprivation in a rotenone treated Zebrafish model of Parkinson disease
      Objective: Among priorities in neurology is the development of a preclinical diagnosis of Parkinson’s dis- ease (PD) by searching for peripheral markers, mostly in body fluids, in patients at an early clinical stage, although there is no evidence that they are also characteristic of preclinical stage.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Publication history

      P-028

      Identification

      DOI: https://doi.org/10.1016/j.parkreldis.2017.11.146

      Copyright

      © 2017 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX